The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice

Lídice Bernardo(Instituto de Medicina Tropical “Pedro Kourí”), María G. Guzmán(Universidad Complutense de Madrid), Sheila Cabezas(Centro de Ingeniería Genética y Biotecnología), Petra Schlick(Intercell (Austria)), Iris Valdés(Centro de Ingeniería Genética y Biotecnología), Lisset Hermida(Centro de Ingeniería Genética y Biotecnología), Lázaro Gil(Centro de Ingeniería Genética y Biotecnología), Ramón Linares(Instituto de Medicina Tropical “Pedro Kourí”), Ricardo Silva(Centro de Ingeniería Genética y Biotecnología), Mayling Álvarez(Instituto de Medicina Tropical “Pedro Kourí”), Eszter Nagy(Intercell (Austria)), Gerardo Guillén(Hunan City University), Alequis Pavón(Instituto de Medicina Tropical “Pedro Kourí”)
Vaccine
May 3, 2011
10.1016/j.vaccine.2011.03.040
Cited by 18

Related Papers

Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance
|Trends in Biochemical Sciences|1998|1.2k
Dengue infection
|Nature Reviews Disease Primers|2016|754
A Compendium of Mutational Signatures of Environmental Agents
|Cell|2019|692
Evaluation of diagnostic tests: dengue
|Nature Reviews Microbiology|2010|588